跳至主要内容
临床试验/NCT06550583
NCT06550583进行中(未招募)不适用

A Clinical Audit on Screening Program for Early Cervical Cancer Detection.

Assiut University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
试验地点
1
主要终点
Screening clinic in Women & Children Hospital

研究概览

简要总结

This study is to audit results and adherence to Cervical Screening program before and after the implementing awareness of the WHO guidelines of screening among the multidisciplinary healthcare workers and patients.

详细描述

Cervical cancer screening is the asymptomatic detection of pre-cancer and cancer in women at risk, with at least one screening suggested for women aged 30-49 years. According to the World Health Survey (2015), 19% of eligible women in developing countries and 63% of those in developed nations had their cervical cancer screening done using a Pap smear or visual inspection with acetic acid (VIA).

According to latest estimates by World Health Organization (WHO), in Egypt, 866 women are diagnosed with cervical cancer every year and 373 die from the disease. Cervical cancer is the 13th most common cancer in women in Egypt and the 10th most common cancer in women aged between 15 to 44 years . Statistics from Egyptian studies provide pre invasive cervical lesion incidence levels of 0.3 % to 0.5 % .

The human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. HPV can be transmitted through sexual contact, including vaginal or oral sex with an infected person. HPV has more than 100 strains, of which HPV16 and HPV18 account for about 70% of invasive cervical cancers

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women 20-60 years.
  • Sexually active.
  • Fulfilling Cervical Check's eligibility criteria for screening at the time of the audit https://www.cervicalcheck.ie/_fileupload/File/Eligibility%20Framework.pdf

排除标准

  • Patient who had underwent to total hysterectomy.
  • Pregnant or postpartum or post abortive patients
  • Patient having any history of treatment for cervical dysplasia.
  • Immunocompromised patients.

结局指标

主要结局

Screening clinic in Women & Children Hospital

时间窗: Baseline

All women undergo Pap smear test according to inclusion criteria and will be adherence to screening program protocol

次要结局

  • Via test(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Mostafa Abdelraof Soliman

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验